What Did Pharma Learn From The COVID-19 Vaccine Development?
Tuesday, August 10, 2021 | 11:00 AM – 11:40 AM PST | Wynn, Mearsault
The successful development of the COVID-19 vaccines in record time has created a transformative moment for the pharmaceutical industry, providing it an opportunity to reintroduce itself to the marketplace as a powerful, positive force for health and patient well-being.
In this session, with 2020 in the rear-view mirror and 2021 in full swing, speakers discuss lessons learned by pharma during the pandemic and the role digital health, interoperability, and real-world evidence will play in reshaping clinical trials and accelerating drug development.
Tuesday, August 10, 2021 | 11:00 AM – 11:40 AM PDT | Wynn, Mearsault
The successful development of the COVID-19 vaccines in record time has created a transformative moment for the pharmaceutical industry, providing it an opportunity to reintroduce itself to the marketplace as a powerful, positive force for health and patient well-being.
In this session, with 2020 in the rear-view mirror and 2021 in full swing, speakers discuss lessons learned by pharma during the pandemic and the role digital health, interoperability, and real-world evidence will play in reshaping clinical trials and accelerating drug development.
Paddy is also speaking at:
Key discussion points:
- Lessons learned by pharma during the pandemic
- How pharma can better partner with healthcare providers to optimize real world evidence
- Keys to reducing costs and time-to-market for pharmaceutical companies
- How AI can help manage large amounts of data.
Speakers
Paddy Padmanabhan, CPHIMS
Chief Executive Officer
Damo Consulting, Inc.
Yvonne Chan, RN
Formally Senior Director for Digital Medicine
Otsuka Pharmaceuticals
Victoria Whitehill
Genentech
